NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
14 September 2024
| Name: | CORUM GROUP LIMITED (COO) (This company subsequently changed its name to PHARMX TECHNOLOGIES LIMITED. You should refer to that name for Status.) | ||||||||||||
| ISIN: | AU000000COO1 | ||||||||||||
| Date of Listing: | 28 July 1971 | ||||||||||||
| Subsequent Names: |
| ||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to PHARMX TECHNOLOGIES LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 000 091 305ABN: 25 000 091 305
Registration Date: 11 December 1950
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now PHARMX TECHNOLOGIES LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| PHARMX TECHNOLOGIES LIMITED | 04/10/2023 | |
| CORUM GROUP LIMITED | 09/11/2006 | 04/10/2023 |
| COSMOS LIMITED | 23/08/2001 | 09/11/2006 |
| MEDICINE QUANTALE LIMITED | 19/02/1997 | 23/08/2001 |
| JEFFERIES INDUSTRIES LIMITED | 19/02/1997 |
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to PharmX Technologies Limited | 04/10/2023 |
The suspension of trading in the securities of Corum Group Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to historical financial matters. | 29/02/2016 |
The company lodges its half yearly report and accounts. | 29/02/2016 |
In reviewing the utilisation of its prior year tax losses, Corum has now recognised a one-off additional $1.4M tax expense in the half-year to December 2015. This arises from work that was originally performed during 2011. This related to the formation of the Corum consolidated tax group. The Company confirms that it has sufficient funds to pay all outstanding tax and that this situation in no way impacts our ability to operate our businesses. | 29/02/2016 |
The securities of Corum Group Limited (the "Company") will be suspended from quotation immediately under listing rule 17.2, at the request of the Company, pending the release of an announcement in relation to historical financial matters that are material. | 25/02/2016 |
securities reinstated to quotation | 02/10/2009 |
securities suspended from quotation following failure to lodge full year accounts | 01/10/2009 |
the suspension of trading in the securities of Corum Group Limited (the "Company") will be lifted prior to the commencement of trading on Monday, 14 September 2009, following receipt of the Company's preliminary final report for the period ending 30 June 2009 | 11/09/2009 |
further to the ASX release of Tuesday 1 st September 2009, the Company advises that the Preliminary Final Report Appendix 4E for the year ended 30 th June 2009 should be lodged with ASX this week | 07/09/2009 |
shares suspended from quotation following failure to lodge half year report and accounts | 01/09/2009 |
name changed from Cosmos Limited | 09/11/2006 |
name changed to PharmX Technologies Limited | 04/10/2023 |
The suspension of trading in the securities of Corum Group Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to historical financial matters. | 29/02/2016 |
The company lodges its half yearly report and accounts. | 29/02/2016 |
In reviewing the utilisation of its prior year tax losses, Corum has now recognised a one-off additional $1.4M tax expense in the half-year to December 2015. This arises from work that was originally performed during 2011. This related to the formation of the Corum consolidated tax group. The Company confirms that it has sufficient funds to pay all outstanding tax and that this situation in no way impacts our ability to operate our businesses. | 29/02/2016 |
The securities of Corum Group Limited (the "Company") will be suspended from quotation immediately under listing rule 17.2, at the request of the Company, pending the release of an announcement in relation to historical financial matters that are material. | 25/02/2016 |
securities reinstated to quotation | 02/10/2009 |
securities suspended from quotation following failure to lodge full year accounts | 01/10/2009 |
the suspension of trading in the securities of Corum Group Limited (the "Company") will be lifted prior to the commencement of trading on Monday, 14 September 2009, following receipt of the Company's preliminary final report for the period ending 30 June 2009 | 11/09/2009 |
further to the ASX release of Tuesday 1 st September 2009, the Company advises that the Preliminary Final Report Appendix 4E for the year ended 30 th June 2009 should be lodged with ASX this week | 07/09/2009 |
shares suspended from quotation following failure to lodge half year report and accounts | 01/09/2009 |
name changed from Cosmos Limited | 09/11/2006 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 11/12/2020 | Jon Newbery | 373,483 | $0.098 | $36,639 |
| 09/12/2020 | Jayne Shaw | 130,000 | $0.093 | $12,038 |
| 03/12/2020 | Jayne Shaw | 270,000 | $0.098 | $26,487 |
| 20/11/2020 | Nick England | 100,000 | $0.090 | $9,000 |
| 09/03/2020 | Jon Newbery | 163,934 | $0.061 | $10,000 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Nick England | Chairman, Interim CEO | 21/11/2019 |
| Peter Wilton | CEO | 10/03/2016 |
| Dennis Bastas | Director | 02/12/2020 |
| Jon Newbery | Director | 25/02/2020 |
| Jayne Shaw | Director | 15/10/2020 |
| Eryl Baron | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Julian Sallabank | Managing Director, CEO | 16/04/2020 | 01/02/2022 |
| David Clarke | Managing Director, CEO | 04/03/2013 | 31/08/2020 |
| Gregor Aschoff | Executive Director | 20/03/2015 | 03/04/2020 |
| Matthew Bottrell | Non Exec Director | 21/08/2015 | 24/02/2020 |
| William Paterson | Chairman | 27/04/2015 | 19/02/2020 |
| David Tonuri | Managing Director, CEO | 17/09/2014 | 02/11/2015 |
| Mark Talbot | Managing Director, CEO | 20/05/2015 | 28/10/2015 |
| Michael Cleary | Non Exec Director | 09/01/2012 | 19/08/2015 |
| Michael Shehadie | Non Exec Chairman | 06/04/2005 | 02/04/2015 |
| Geoffrey Broomhead | Managing Director, CEO | 01/09/2009 | 30/01/2015 |
| Glenn Brown | CFO | 01/10/2008 | 01/02/2013 |
| Peter Bradfield | Independent Director | 01/09/2009 | 09/01/2012 |
| Doug Halley | Director | 06/10/2009 | 24/11/2010 |
| Craig Glendenning | Executive Director | 04/10/2007 | 04/09/2009 |
| Mark Winnett | Managing Director | 07/03/2005 | 02/09/2009 |
| Michael Rowley | Executive Director | 30/11/2005 | 28/11/2008 |
| Peter Kelly | Non Exec Director | 07/03/2005 | 05/11/2006 |
| Henry Preston | Chairman | 20/02/2002 | 08/04/2005 |
| Nigel Purves | Managing Director, CEO | 19/11/2002 | 09/03/2005 |
| Robert Tynan | Non Exec Director | 28/05/2002 | 09/03/2005 |
| John Burrows | Chairman | 04/09/2001 | 28/11/2002 |
| Paul McGlone | Managing Director | 28/04/2000 | 31/05/2002 |
| Peter Noble | Non Exec Director | 17/02/1999 | 22/02/2002 |
| Gary Garton | Executive Director | 01/03/1997 | 06/09/2001 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
